European Consumers' Tools to Retrieve Health Information Online

Manhattan ResearchSearch engines and Wikipedia play a major role in how European consumers retrieve health information online, reports leading global pharmaceutical and healthcare research firm Manhattan Research from its Cybercitizen® Health Europe v8.0 strategic research and advisory service. With the lack of comprehensive, accredited health portals in many European markets, these tools fill the gap for consumers looking for disease, symptom, treatment, and product information relevant to their language and locality.

The majority of adults online in Europe used search engines to look up health information in the past 12 months, and many report that they turn to a search engine first over going directly to a health site when beginning their quest for information. The collaborative online encyclopedia Wikipedia ranks as a top site used for health in most of the countries surveyed in Cybercitizen® Health Europe.

"Healthcare companies should monitor local Wikipedia sites to ensure that brands and products are represented accurately. The majority of online European consumers expect that pharmaceutical, biotech, and medical device companies monitor Wikipedia entries about their products," said Meredith Abreu Ressi, Vice President of Research at Manhattan Research. "Of course it is important for companies to be vigilant in their approach to editing or altering Wikipedia entries. Making sure that content is complete is one thing - selective removal of content is clearly another."

Cybercitizen® Health Europe is a syndicated multi-client study and advisory service focused on key research topics and trends impacting the European consumer health marketplace - with the goal of enabling companies to make better informed decisions when planning and executing marketing strategies. The study was fielded online among 4,079 European consumers from the United Kingdom, Germany, Spain, Italy, France, Belgium, Sweden, the Netherlands, Poland, and Portugal. For additional product information, please visit www.manhattanresearch.com/ccheu.

Strategic White Paper
The "Connecting with Europeans Online for Health" white paper is derived from Manhattan Research's Cybercitizen® Health Europe v8.0 study and advisory service and contains key market data, trends and strategies for pharmaceutical and healthcare companies. Access the paper here: www.manhattanresearch.com/research/white-papers/
connecting-with-europeans-online-for-health.aspx

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory firm for pharmaceutical and healthcare companies. For more information, visit www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

Most Popular Now

Primary endpoint met in COMET-TAIL Phase III trial…

GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Vir) (Nasdaq: VIR) announced headline data from the randomised, multi-centre, open-label COMET-TAIL Phase...

Merck and Ridgeback's molnupiravir, an oral COVID-…

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced that the United Kingdom Medicines and Healthcare products Re...

Johnson & Johnson COVID-19 vaccine named one o…

The editors of Time announced that the Johnson & Johnson COVID-19 vaccine has been selected as one of Time's Best Inventions of 2021. The vaccine, for which Johnson & ...

New target for COVID-19 vaccines identified

Next generation vaccines for COVID-19 should aim to induce an immune response against 'replication proteins', essential for the very earliest stages of the viral cycle, c...

Safety concerns raised for neuroblastoma candidate…

St. Jude Children's Research Hospital scientists looking for drugs to improve survival of children with high-risk neuroblastoma found a promising candidate in CX-5461. Th...

Two billion doses of AstraZeneca’s COVID-19 vaccin…

AstraZeneca and its partners have released for supply two billion doses of their COVID-19 vaccine to more than 170 countries across every continent on the planet in the l...

Pfizer's novel COVID-19 oral antiviral treatment c…

Pfizer Inc. (NYSE: PFE) today announced its investigational novel COVID-19 oral antiviral candidate,PAXLOVID™, significantly reduced hospitalization and death, based on a...

'Dancing molecules' successfully repair severe spi…

Northwestern University researchers have developed a new injectable therapy that harnesses “dancing molecules” to reverse paralysis and repair tissue after severe spinal ...

Repurposing a familiar drug for COVID-19

For the past year and a half, the COVID-19 pandemic has continued to engulf the globe, fueled in part by novel variants and the uneven distribution of vaccines. Every day...

Researchers reveal a strategy for next-generation …

A study led by the Garvan Institute of Medical Research has revealed a guide to developing COVID-19 vaccines that both prevent the coronavirus from infecting human cells ...

A target for potential cancer drugs may, in fact, …

In recent years, much scientific effort and funding has focused on developing drugs that target an enzyme with the unwieldy name of Src homology 2-containing protein tyro...

A commonly found parasite could treat certain type…

Scientists have discovered that a deadly parasite, known to cause ill health in pregnant women and immunocompromised patients, could potentially be used to treat various ...